Application ID | 3301135 |
Status | Abandoned |
Date of Application | 05 July 2016 |
Class(es) | 5 |
Type | Device |
Registration State | Maharashtra |
Country | India |
Published | Journal 1910 |
Details | [CLASS : 5] PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND DIETETIC SUBSTANCES ADAPTED FOR MEDICAL USE. |
Examination Report | 2016-11-16 |
1 | Additional Representation Sheet | 2016-07-05 |
2 | TM-1 | 2016-07-05 |
3 | Authorization Document (POA) | 2016-07-05 |
4 | Reply to Exam Report (MIS-R) | 2017-07-28 |
5 | Journal Copy | 2019-08-09 |
6 | TM-O(NOTICE OF OPPOSITION) | 2019-11-01 |
1 | Dispatching Of Examination Report For : 3301135 | 4860287 | 2103737 | 21/06/2017 |
2 | Hearing Notice (Show Cause) | 7235915 | 3488090 | 29/11/2018 |
3 | Hearing Notice (Adjourned) | 8351348 | 4175377 | 21/06/2019 |
4 | Tribunal Accepted Notice For : 3301135 | 8532619 | 4214112 | 04/07/2019 |
5 | Opposition Notice | 9190243 | 4515378 | 04/11/2019 |
6 | Order Form Of 21(2) | 10217054 | 4929338 | 29/07/2020 |
The application for Lamotigin was made on 05 July 2016.
The trademark applicant for Lamotigin is Rex Genia Life Sciences.
Lamotigin is applied in class(es) 5.
Application for Lamotigin is on Abandoned stage.
Application Id allotted to Lamotigin is 3301135.
Trademark agent or attorney for the application is G. Paramesh.
Lamotigin filed with the Intellectual property office as a DEVICE.